ALLRAS Trademark

Trademark Overview


On Wednesday, August 28, 2013, a trademark application was filed for ALLRAS with the United States Patent and Trademark Office. The USPTO has given the ALLRAS trademark a serial number of 86050404. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 24, 2021. This trademark is owned by GOLDEN BIOTECHNOLOGY CORPORATION. The ALLRAS trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for ...
allras

General Information


Serial Number86050404
Word MarkALLRAS
Filing DateWednesday, August 28, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 24, 2021
Registration Number4689447
Registration DateTuesday, February 17, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAdjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 24, 2021
Primary Code005
First Use Anywhere DateWednesday, August 28, 2013
First Use In Commerce DateTuesday, August 19, 2014

Trademark Owner History


Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Taipei City
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Taipei City
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Taipei City
TW

Trademark Events


Event DateEvent Description
Friday, September 24, 2021CANCELLED SEC. 8 (6-YR)
Monday, February 17, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 17, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, January 15, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 14, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 14, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, December 5, 2014USE AMENDMENT FILED
Tuesday, January 13, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 5, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, October 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 11, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 3, 2014ASSIGNED TO LIE
Tuesday, June 17, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 29, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 29, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 29, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 16, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 16, 2013NON-FINAL ACTION E-MAILED
Monday, December 16, 2013NON-FINAL ACTION WRITTEN
Wednesday, December 11, 2013ASSIGNED TO EXAMINER
Friday, September 6, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 31, 2013NEW APPLICATION ENTERED IN TRAM